ENESTPath Patient’s Voice Italian Substudy [Italy]
Study title
ENESTPath Patient’s Voice Italian Substudy
Scientific title
CML patient’s voice: A pilot sub-study exploring the emotional experience of patients during CAMN107AIC05 Study – Italian substudy of ENESTPath (clinicaltrials.gov NCT01743989, EudraCT 2012-005124-15
Type of study
Treatment discontinuation trials
Current status
No longer recruiting
What is the purpose of the study
Patients from Italian centres participating in ENESTPath will undergo specific Quality of Life and psychological assessments during the consolidation and treatment-free remission phase.
The following tools will be used:
- Patient Diary
- EORTC QLQW-C30: a questionnaire to assess the quality of life of cancer patients
- EORTC-CML: a questionnaire to assess the quality of life of CML patients
- Sixteen Personality Factor Questionnaire (16PF): a self-report personality test;
- Symptom Checklist 90 (SCL.90-R): a self reported questionnaire
Key inclusion criteria
Patients in consolidation study phase of ENESTPath who will perform visit 6 at the time of sub-study activation
Key exclusion criteria
Where can I find additional information
…
Study sponsor
Novartis
Scientific lead / contact
Claudia Galimberti Novartis Farma S.p.A.
Principal investigator
Luca Dezzani Novartis Farma S.p.A.
Study centers / principal investigators
Italian centers participating in ENESTPath